← Back to signals
RLYB
Rallybio Corporation
Research: Finviz ↗·Perplexity ↗
No convergence signal this quarter — shown because tracked funds have filed 13D/G on this stock.
Days to cover (short int.)
5.5d↑+0.7%
as of 2026-08-31
Fund 13D/13G Filings (2)
Tracked funds' beneficial-ownership filings on this stock — disclosed within days of a position change, fresher than the quarterly 13F. Since Filing compares the stock to SPY from the filing date (shown for filings within the last 90 days).
| Fund | Form | ∆ Shares | % of Class | Since Filing | Filed | Src |
|---|---|---|---|---|---|---|
| Viking Global | SC 13G/A | — | 10.0% | +13.1% vs SPY +18.6% abs | 2026-05-15 | ↗ |
| Viking Global | SC 13G/A | — | 10.0% | — | 2026-02-17 | ↗ |
Tracked Funds Holding (1)
| Fund | Manager | Shares Held | Position Value |
|---|---|---|---|
| Viking Global | Andreas Halvorsen | 524K | $8M |
Quarter-end 13F positions for the tracked funds holding this stock.